India has a moral obligation to participate in clinical trials
Milind Rege, Clinical Team Leader – Clinical Monitoring, SIRO Clinpharm and Dr Shubhangi Desai, Head Clinical Operations - Asia…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Management
Need to take a pragmatic view of clinical trials
Kiran Mazumdar-Shaw, Chairman and Managing Director, Biocon says that without trials there is no way pharmaceutical research can…
Without ethics, there is no credibility for clinical trials
Amar Jesani, Editor, Indian Journal of Medical Ethics, says ethical considerations are absolutely essential for upholding the…
Clinical trials: Safety of research participant is the ethical mandate!
Dr SV Joga Rao, Advocate, Solicitor & Healthcare Consultant, Legalexcel, Bengaluru, shares his experiences about the role,…
Celebrating the new era of clinical research in India on International Clinical Trials day
Paula Brown Stafford, Global Head, Clinical Development, Quintiles, gives an insight about the challenges of clinical research and…
Accident analysis
Recent explosions at pharmaceutical and chemical plants have raised serious questions over the safety procedures supposedly being…
The new patent law, policy and strategy
Anand Nandkumar, Assistant Professor of Strategy, Indian School of Business, provides an overview of the long-term implications of…
‘Tweet-talk’ your customers with new age marketing
As a continuation to the series of articles titled ‘The Digital Dose for Indian Pharma’, Dinesh Chindarkar, Co-founder & Vice…
Towards sustainable CSR
Companies will need to part with two per cent of their precious profits to fund their CSR programmes, if the new provisions of the…
SC verdict on Glivec: An IP milestone
Experts stress that the verdict should not be seen as a case of weak IP rights. An Express Pharma report